A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

AIMS: Androgen deprivation therapy (ADT), usually achieved with luteinising hormone releasing hormone analogues (LHRHa), is central to prostate cancer management. LHRHa reduce both testosterone and oestrogen and are associated with significant long-term toxicity. Previous use of oral oestrogens as A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Oncol (R Coll Radiol)
Hlavní autoři: Gilbert, D.C., Nankivell, M., Rush, H., Clarke, N.W., Mangar, S., Al-hasso, A., Rosen, S., Kockelbergh, R., Sundaram, S.K., Dixit, S., Laniado, M., McPhail, N., Shaheen, A., Brown, S., Gale, J., Deighan, J., Marshall, J., Duong, T., Macnair, A., Griffiths, A., Amos, C.L., Sydes, M.R., James, N.D., Parmar, M.K.B., Langley, R.E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2024
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7617162/
https://ncbi.nlm.nih.gov/pubmed/37973477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clon.2023.10.054
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky